7月15日，Celcuity Inc盘后下跌6.75%，报106.79美元/股，成交额332.07万美元。
Celcuity Inc所在的生物科技行业中，个股中，艾伯维公司跌0.03%，Nextcure Inc.跌12.61%，渤健公司涨0.45%，吉利德科学涨0.17%，Revolution Medicines, Inc.跌0.52%。
Celcuity Inc.是一家临床阶段的生物技术公司，专注于开发针对实体瘤的靶向疗法。其主要候选药物gedatolisib是一种PI3K/AKT/mTOR通路激酶抑制剂，目前正在进行针对HR+/HER2-晚期乳腺癌及其他适应症的3期临床试验。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.